Press releaseGlobe Newswire
Biomerica
BMRA · NASDAQ
$1.72−$0.0413 (−2.35%)TodayMarket closed ·
Prev close $1.76
Latest news
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
Biomerica Reports Fiscal 2026 Year-End Financial Results
- NewsCaroline Ryan
Deal Dispatch: Carets Corp Explores Strategic Alternatives, nVent Electric Buys Maverick Power for $1.75 Billion, BioXcel Bankruptcy
- Press releaseGlobe Newswire
Biomerica Announces $2.23 Million Financing
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
- Press releaseBusiness Wire
ConsumerDirect Expands Executive Team with Appointment of Gary Lu, CPA as Chief Financial Officer
- Press releaseGlobe Newswire
Biomerica's inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026
- Press releaseGlobe Newswire
Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway
- Press releaseGlobe Newswire
Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs
- Press releaseGlobe Newswire
Biomerica Reports Third Quarter Fiscal 2026 Financial Results
- News
Biomerica Receives First Commercial Order For Hp Detect, Helicobacter Pylori Diagnostic Stool Antigen Test
- Press releaseGlobe Newswire
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
- Press releaseGlobe Newswire
Vietnam Approves Biomerica's EZ Detect™ for Nationwide Distribution
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsAvi Kapoor
Crude Oil Moves Higher; Travelers Earnings Beat Estimates
- NewsAvi Kapoor
Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings
- News
Watching Biomerica; Co Named In 'Research Shows Blood Test May Provide Personalized Dietary Therapy For Patients With Irritable Bowel Syndrome'; Michigan Medicine And Cleveland Clinic Study Finds Blood Test-Guided Diet Reduces Abdominal Pain In IBS Patients
- News
Apple, Rivian, Unitedhealth, Biomerica, Tesla: Why These 5 Stocks Are On Investors' Radars Today
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Nasdaq Down 150 Points; Morgan Stanley Earnings Top Estimates
- NewsAvi Kapoor
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
- NewsAvi Kapoor
US Stocks Edge Lower; Retail Sales Increase Less Than Expected
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.